Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.
1996 · The EMBO Journal · 770 citations
https://doi.org/10.1002/j.1460-2075.1996.tb00603.x
M
Michael Sela
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
656
Papers
29.0K
Citations
86
h-index
433
i10-index
Michael Sela is an academic researcher from Bar-Ilan University. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Glycosylation and Glycoproteins Research & Immunotherapy and Immune Responses. The author has an h-index of 86, co-authored 558 publications.
Papers by this author
worksThe ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors
1999 · Proceedings of the National Academy of Sciences · 444 citations
https://doi.org/10.1073/pnas.96.9.4995
Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth
2013 · Proceedings of the National Academy of Sciences · 158 citations
https://doi.org/10.1073/pnas.1302594110
Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR
2013 · Proceedings of the National Academy of Sciences · 113 citations
https://doi.org/10.1073/pnas.1220763110
The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin
1998 · Oncogene · 99 citations
https://doi.org/10.1038/sj.onc.1201642
c-Cbl Is a Suppressor of the Neu Oncogene
2000 · Journal of Biological Chemistry · 73 citations
https://doi.org/10.1074/jbc.m002661200
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat